middle.news
How Is Tissue Repair Advancing Its Phase 3 Trials and 2026 Product Launch?
1:31pm on Wednesday 29th of October, 2025 AEDT
•
Healthcare
Read Story
How Is Tissue Repair Advancing Its Phase 3 Trials and 2026 Product Launch?
1:31pm on Wednesday 29th of October, 2025 AEDT
Key Points
35 patients randomized across two Phase 3 trials for TR987®
Partnership with Advanced Cosmeceuticals expands TR Pro+® clinic network
Regulatory progress includes FDA drug classification and ongoing 510(k) and CE mark submissions
Cash position of $10.3 million with $1.97 million net operating outflow in the quarter
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Tissue Repair (ASX:TRP)
OPEN ARTICLE